01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/2025

Jan 27, 2025, 16:40 | Science
Francisco Conesa Buendía: Unveiling the Long-Term Safety of CAR-T and Gene-Modified T Cell Therapies
Francisco Conesa Buendía, Assistant of Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Jan 27, 2025, 16:25 | Insight
Highlights From The 2025 FLASCO Early Lung Cancer Summit by Estela Rodriguez
The 2025 FLASCO Early Lung Cancer Summit was held on January 24-25, bringing together experts…
Jan 27, 2025, 15:58 | Blog
Tom Powles: Bladder sparing approaches after EVP is likely to be the SoC in MIBC
Tom Powles, Professor at the University of London, shared a post on X: "The muscle…
Jan 27, 2025, 15:54 | Blog
Katy Beckermann: We NEED the NIH to keep advancing research
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared a post by…
Jan 27, 2025, 15:50 | Blog
Jennifer Douglas: Cancer is hard, physically, mentally, and emotionally
Jennifer Douglas, Writer and DCIS Breast Cancer Patient Advocate, shared a post on LinkedIn: “Cancer…
Jan 27, 2025, 15:43 | Blog
Dégi László Csaba: Unveiling disparities in cancer care - a comparative study of service availability in LMICs vs HICs
Dégi László Csaba, President of the European Cancer Organisation, shared a post on LinkedIn: "Excited to…
Jan 27, 2025, 15:39 | Career
Avrum E. Spira - Candidate for Board of Directors of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote…
Jan 27, 2025, 15:39 | Blog
Daniel Haldar: Honored to give my first oral presentation ASCO GI
Daniel Haldar, Assistant Professor of GI Medical Oncology at MD Anderson Cancer Center, shared a…
Jan 27, 2025, 14:40 | Blog
Tanja Obradovic: Lessons from 2024 for successful oncology drug development strategy
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "What…
Jan 27, 2025, 13:16 | Insight
FDA Approved GRAFAPEX for Allogeneic HSCT in AML/MDS
On January 22, 2025, Medexus announced that the FDA had approved GRAFAPEX, an alkylating agent,…
All: 2689 Posts: 441 - 450
Special Coverage